Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sarepta still on track for eteplirsen NDA next year, says Piper Jaffray
Sarepta still on track for eteplirsen NDA next year, says Piper Jaffray
Sarepta still on track for eteplirsen NDA next year, says Piper Jaffray
Submitted by
admin
on October 4, 2013 - 12:40pm
Source:
Yahoo/Fly on the Wall
News Tags:
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Headline:
Sarepta still on track for eteplirsen NDA next year, says Piper Jaffray
Do Not Allow Advertisers to Use My Personal information
